Press Release: Filament Health Files 20th Patent Application Including Three International PCT Applications

CANNANNEW REPORT

Filament has been issued the first patent for the extraction and standardization of natural psilocybin and intends to further develop its IP portfolio Vancouver, British Columbia, September 1, 2021 – Filament Health Corp. (NEO:FH) (“Filament” or the “Company”), a leading exclusively-natural psychedelic drug development company, today announced that it has filed its 20th patent application in support of the Company’s research phase programs. These filings include three international Patent Cooperation Treaty (PCT) patent applications. “This milestone sets us ahead of industry peers and demonstrates the strength of our IP strategy,” said Benjamin Lightburn, Chief Executive Officer. “Many naturally occurring compounds have great potential to alleviate suffering, and our patent filings cover a range of innovative technologies necessary for transforming the healing power of those compounds into pharmaceutical standardized form.” Prior to Filament’s issuance of the first patent for natural psilocybin extraction and standardization on August 3rd, 2021, the Company filed a US nonprovisional patent application as well as a PCT application claiming priority to the issued patent. The Patent Examiner’s allowance and issuance of all claims is demonstrable evidence of the patent’s novelty, inventive steps, and utility. The patent includes claims to the processing, extraction, and standardization of psychoactive compounds to support the company’s clinical research programs. “We will leverage our success in Canada by utilizing the Patent Prosecution Highway (PPH) in the United States and internationally,” said Taran Grey, Director of Intellectual Property. “This will allow Filament to achieve patent issuance more quickly as the PPH uses fast-track examination procedures among participating patent offices such as those in the US, Canada, and Europe.”

Excerpt only …
READ MORE BELOW
Source : Press Release: Filament Health Files 20th Patent Application Including Three International PCT Applications

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.